chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a health professional concerning a 4 year old patient who "about two weeks ago" on approximately 10-Feb-2004 was vaccinated SC in the right upper arm with a first dose of varicella virus vaccine live (lot "0805N"). "Today" on 24-Feb-2004 the patient's mother reported that the child has 24 pox around around arms and back of knees. The child did not have a fever. Unspecified medical attention was sought, but prescription drug treatment was not required. No product quality complaint was involved. No additional information was given at this time. Additional information has been requested.   Follow up report, Concomitant vaccinations the same day included a fifth dose IM in the left deltoid of diphtheria toxoid (+) pertussis acellular Biken vaccine (+) tetanus toxoid (manufacturer unknown), a fourth dose IM  in the right deltoid of inactivated poliovirus vaccine (manufacturer unknown)  and a second dose SQ in the left upper arm of measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). There was no illness at the time of vaccination. Follow up information indicated that the child broke out on 02/22/2004 with approximately 2 dozen pimple like pox. Only a few of them were vesicle filled. The report indicated that they were located on the trunk. 1 on back and in the armpit and knees and elbows. There were no labs or diagnostic test done. It was reported that by 02/25/2004 they had dried up and by 02/27/2004 They were mostly gone. It was also reported that the patient recovered. No additional information is expected.
shingles for about 8 months, had to visit ER; This case was reported by a consumer via call center representative and described the occurrence of shingles in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (in may 2020, three and a half months before the vaccination).   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, 3 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: This case was reported by the patient's spouse. The age at vaccination was not reported. The reporter stated that 3 days after the Shingrix vaccine patient had developed a horrific case of shingles. The patient had to visit the emergency room.. The reporter stated patient had the shingles for about 8 months. The patient was very concerned about getting the second Shingrix dose.  Reporter never clarified if spouse did or did not get the second dose. No further information was available. The demographics of patient and date of birth were not obtained. No lot or expiration date information was provided. The reporter stated that no one told patient any different about getting the vaccine or that he should have waited even more time to get the vaccine after the Shingles episode. Patient's health care professional was aware of patient's previous case of Shingles three and half months before. The health care professional that provided the injection to patient was also aware that patient had a previous case of Shingles three and half months before. According to the reporter the adverse event was reported to the CDC. Consent for follow up was not obtained.
Mother stated that she started having left arm swelling and redness on 8/29/2007. Arm was swollen and red from shoulder to elbow. She also had low grade fever, decrease appetite and stomach ache
extreme upper body muscle pain; terrible fatigue; low blood pressure/The diastolic is what was low, it was like 52; booster; sleeping "14 hours a day; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP) from medical information team.  An 84-year-old male patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 01Nov2021 13:55 (Lot number: FE3590) at the age of 84 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "heart disease" (unspecified if ongoing), notes: Verbatim: Heart disease, Additional Information for Other Conditions: This is the main concern. His heart is doing fine now; "Age" (unspecified if ongoing), notes: Verbatim: Age; "Cholesterol" (unspecified if ongoing); "Blood pressure" (unspecified if ongoing); "Leg cramps" (unspecified if ongoing). Concomitant medication(s) included: COREG taken for cardiac disorder (ongoing); SIMVASTATIN taken for hypercholesterolaemia (ongoing); LISINOPRIL taken for hypertension (ongoing); ASPIRIN [ACETYLSALICYLIC ACID] (ongoing); POTASSIUM taken for muscle spasms (ongoing). Vaccination history included: Bnt162b2 (second dose, Card is so messed up can hardly read it to provide product details. , Exact dates of first and second dose of Pfizer Covid Vaccine unknown to caller. , Second Dose Lot- EN5318 , Exp Unknown, thinks given in Apr, but not sure), administration date: Apr2021, when the patient was 84 years old, for COVID-19 immunization; Bnt162b2 (first dose, Card is so messed up can hardly read it to provide product details. , Exact dates of first and second dose of Pfizer Covid Vaccine unknown to caller. , First Dose Lot-EL3248 , Exp, Unknown), for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 01Nov2021 13:55, outcome "unknown", described as "booster"; MYALGIA (non-serious) with onset 02Nov2021 07:00, outcome "recovering", described as "extreme upper body muscle pain"; FATIGUE (non-serious) with onset 02Nov2021 07:00, outcome "recovering", described as "terrible fatigue"; HYPOTENSION (non-serious) with onset 02Nov2021, outcome "not recovered", described as "low blood pressure/The diastolic is what was low, it was like 52"; SOMNOLENCE (non-serious) with onset Nov2021, outcome "unknown", described as "sleeping "14 hours a day". The events "extreme upper body muscle pain" and "terrible fatigue" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of myalgia. Additional information: Patient did not get a Covid test. He was just told to drink plenty of water for the muscle pain and take Extra Strength Tylenol for muscle pain- 500mg, one prn. The events resulted in visit to Emergency Room. No follow-up attempts are possible. No further information is expected.
PFIZER VACCINE #3 GIVEN 8/19/21, LOT #FC3183; 1/10/22 pt to ED with increasing SOB, generalized fatigue, nasal congestion, productive cough, diarrhea; states was diagnosed with COVID 1 wk prior to ED; COVID test positive in ED as well; O2 sats on 2 L via NC were 69% in ED; placed on NRB with improvement; transferred to ICU; AHRF secondary to COVID pneumonia; given IV Solu-Medrol, baricitinib, ASA, Lovenox, remdesivir; respiratory status continued to worsen requiring intubation with mechanical ventilation; pt continued to decline; pt became unresponsive, asystole; expired at the hospital
26JUL97 10PM low grade fever;27JUL97 8AM hives, severe urticaria;fever >101 oral;tx w/oral DPH w/no relief;rash started on neck;18JUL98 AM fever 103 called MD who phoned in an ATB;ATB & APAP not helping fever;to ER for t104;
Initially felt body aches which resolved with motrin.  Went to bed and woke up at 3am curled into a ball unable to get warm.  Was shaking and had bad body aches.  Got up and took motrin and was able to go back to sleep after an hour or so.  Woke up around 5:30, had 100.9 temp, body aches and felt hot.  Took more motrin, called off of work and went back to bed.  Took motrin all day as indicated on directions.  Started feeling better around 4pm and by 8pm felt completely fine, just tired.  By next day back to normal.
one week later, swelling of lymph node under the armpit of the injection site; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (one week later, swelling of lymph node under the armpit of the injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (one week later, swelling of lymph node under the armpit of the injection site). At the time of the report, LYMPHADENOPATHY (one week later, swelling of lymph node under the armpit of the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included birth control pills. No treatment information provided.
covid test result Positive; post nasal drip; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE2), via an unspecified route of administration, administered in Arm Left on 02Mar2021 13:15 (at age 60-year-old) (Batch/Lot Number: EL3247) as 1st dose, single for covid-19 immunisation. Medical history included stage 0 breast cancer survivor and surgical tape allergies. Patient was not pregnant and was not previously diagnosed with COVID-19. No other vaccines in four weeks was administered. Concomitant medication included ergocalciferol (VIT D), calcium (ALGAE CALCIUM), and strontium. On 11Mar2021 22:00, patient started with post nasal drip, cough and runny nose. She got progressively worse with headache, chills and fatigue on 12Mar2021. Overnight to 13Mar2021, the runny nose, post nasal drip and cough greatly was reduced but she was still fatigued, had headache, and very little chills. Patient called health network and was screened for a Covid 19 Test. Patient had the Covid Test (nasal swab) on 13Mar2021 with positive results. No treatment was received for the events. Events resulted in healthcare professional office/ clinic visit. Outcome of the events was recovering.
fever; flu like symptoms; This case was reported by a nurse via sales rep and described the occurrence of fever in a 17-year-old male patient who received Men B NVS (Bexsero) for prophylaxis.   In August 2019, the patient received the 1st dose of Bexsero. In August 2019, 2 hrs after receiving Bexsero, the patient experienced fever and influenza-like symptoms. The patient was treated with ibuprofen. On an unknown date, the outcome of the fever and influenza-like symptoms were recovered/resolved.   It was unknown if the reporter considered the fever and influenza-like symptoms to be related to Bexsero.  Additional details were provided as follows: The patient received Bexsero vaccine about a week ago from time of reporting. After about 2 hours the patient experienced fever, and flu like symptoms. The patient was given ibuprofen and fever, flu like symptoms went down right away. The nurse did not think it was serious enough to report, since side effects went away shortly after. Agreed to follow up if need be.
Petechiae on face immediately after receiving vaccines. Watched for 30 min. Prednisone 10mg given
Patient was able to schedule into our clinic, even though he is under the age of 16.  His parent was with him.  He received the vaccine before we recognized that he was under 16.  Patient tolerated the injection with no issue.
Onset of approx. 100 "pox marks" filled with clear fluid, 13 days post vax. No prior exposure to chickenpox. She has 3 siblings and 2 have been vaccinated against varicella; 1 had natural case of chickenpox in the past. Lesions appear "all over the body". Denies rash, fever. No frequent illnesses/rashes.
Residual nerve pain; Probably had some discomfort of the (injected) arm; Not gone to get Shingrix shot number 2; Shingles on her head, eye; Terrible case of shingles on her head, eye, temple, scalp area; This case was reported by a consumer via call center representative and described the occurrence of ophthalmic herpes zoster in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 29th March 2019, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. In May 2019, 8 weeks after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced ophthalmic herpes zoster (serious criteria GSK medically significant) and shingles. On an unknown date, the patient experienced nerve pain, arm discomfort and incomplete course of vaccination. On an unknown date, the outcome of the ophthalmic herpes zoster and nerve pain were not recovered/not resolved and the outcome of the shingles was resolved with sequelae and the outcome of the arm discomfort was recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the ophthalmic herpes zoster, shingles, nerve pain and arm discomfort to be related to Shingrix.  Additional case details were reported as follows: The patient reported case for herself. The patient received vaccine in left deltoid. She did not know if it was given intramuscularly because she did not look at the size of the needle. She did not have the lot number/expiry date but did provide the name and contact information of the pharmacy who administered it. She stated that she did not remember having any side effects after receiving the shot but she said she probably had some discomfort of the (injected) arm. Eight weeks after having the shot she developed a terrible case of shingles on her head, eye, temple, scalp area. The patient was not fully recovered because she still had residual nerve pain on the left side of her head. The patient did not went get Shingrix shot number 2 and she had past the 6 month window, which led to incomplete course of vaccination. She stated that her primary care physician wants her to get the Shingrix shot number 2. She spoken with a pharmacy and they told her that she would have to re-start the series but the patient did not want to restart the series. The reporter consented to follow up. This was a medication error with harm.
Significant body aches and chills - very similar to what flu feels like.   No fever and nothing respiratory.   Stay in bed - took Extra Strength Tylenol and drank hot liquids, tried to sleep for 24 hour duration of symptoms.
48yoM (h/o childhood asthma, GERD, lipomas, preDM, obesity BMI 30) who had Covid J&J vaccine 3/12/21, then 4/4/21 had dizziness and a little SOB, seen in ER with neg brain MRI/MRA and trop/EKG neg. and labs.  Later had DDIMER 560 on 4/15/21 due to h/o J&J vaccine and CTA lung 4/29/2021 shows Right lower lobe pulmonary emboli.  Patient is clinically much better. No more SOB. Dizziness a little residual but significantly better. Never had hypoxia/tachycardia and BP always reassuring. Pt read about some blood thinner making clot worse and doesn't want to to start a blood thinner without checking with hematology first. I've prescribed rivaroxaban so that pharmacy can start authorization and ensure coverage, but patient strongly states that he will not take it yet until hearing from hematology.
DIFFICULTY BREATHING WHEN LAYING DOWN, SHORTNESS OF BREATH; DIFFICULTY BREATHING ON EXERTION; This spontaneous report received from a patient concerned a 39 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, penicillin allergy, and non-smoker. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 1808986, and expiry: 04-JUL-2021) dose was not reported, administered on 29-MAY-2021 for prophylactic vaccination. Concomitant medications included lisinopril for high blood pressure. On 30-MAY-2021, the subject experienced difficulty breathing when laying down, shortness of breath. On 30-MAY-2021, the subject experienced difficulty breathing on exertion. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from difficulty breathing when laying down, shortness of breath, and difficulty breathing on exertion. This report was non-serious.
Fatigue, pain at injection site, headache, chills 7:00 4-16 through 4-17;
PATIENT WAS TIRED AND WEAK THE NEXT MORNING (11/8) AND NEEDED HELP GETTING OUT OF BED. HE ALSO NEEDED HELP PART OF THE DAY , APPROXIMATELY 12 HOURS, TO WALK AND GET AROUND THE HOUSE. THIS LASTED FOR 12 HOURS AND THEN WAS FINE. NO PROBLEMS WITH BP, BREATHING, DID NOT FEEL FAINT OR HAVE A RASH.
pt recv vax 13SEP95 & 12SEP9  fever of 102 not feeling well;13SEP96 pt devel first lesions described as red raised bumps;14SEP96 pt had 10 to 15 red bumps on upper body & 5 to 10 on legs;then 100 lesions all over pt body; dx varicella
Pt received vaccine on 2/19/03. On 2/22/03 low grade temp, soreness at site, aches and pain. Red rash right lower arm and hand on 2/23/03. Rash gone on 2/25/03.
Initial report was report was received on 07 August 2014 from a health care professional. A 51 year-old female (date of birth not reported) had received on 22 July 2014 an intramuscular left deltoid injection of ADACEL, lot number U4874AA and one day later on 23 July 2014, experienced severe swelling and pain. The patient was evaluated by a physician and was diagnosed with cellulitis. Treatment included BENADRYL and MEDROL pack. The patient had no illness at the time of vaccination. Past medical history was not provided. Relevant diagnostic tests were not reported. Outcome was unknown. The reporter for this case is the same as for case 2014SA108506 and 2014SA108507. Documents held by sender: none.
extreme diarreah extreme weakness,  I could not walk straight or without help Chest pressure and tingling dizziness and confusion uneven breathing chills fever feeling  Rubbery legs (I walked like I was extremely drunk)  I fell against a few wall until my husband helped me to the bathroom, in the  tub, then back to bed.  I told my husband to be ready to call 911 if I didn't start feeling better. I woke up at 6:30 feeling somewhat better.
Delayed reaction at site: red 4"x6" spot lasted 5 days; hot to touch (did not hurt nor itch).  Swollen lymph nodes near collar bone; larger on side opposite where I got shot.  Still have the swollen lymphnodes; the swelling comes and goes. Smaller reactions that I am not sure are related to shot but may very well be. Day after shot: small 1"x3" rash on chest opposite side of where I got shot.  This was a raised rash like average dermititis but was itchy and went away in about a week.  Day of shot had a canka sore on tongue that was gone the next day. but replaced by a sore on the side of my cheek that also went away in one day.  Had a swollen gland around the time the lymph nodes started to swell.  This is unusual because I don't work or see anyone except my husband, who is fully vaccinated and my daughter who is always home since covid broke out last year.  I don't go to stores nor anywhere else except for the one outing to get a dr's note for the vaccine and of course the day of the vaccine.  The swollen gland was gone in a day. That is why I think these are all vaccine related side effects.
Narrative:  COVID infections following completion of COVID vaccine series 04/02/21 COVID vaccine dose #1 (J&J) 07/16/21 Pt reports holding on starting tofacitinib for RA until he recovers from "cold" 07/28/21 Pt reports "chest cold" x1 week, coughing up phlegm; still waiting to start tofacitinib; states he was tested at local pharmacy for COVID that morning; rx given for DM/guaifenesin, cephalexin; COVID POSITIVE 07/29/21 Pt reports congestion, productive cough, runny nose, mild shortness of breath; rx given for albuterol, ascorbic acid, zinc 07/30/21 Pt reports cough, fatigue 07/31/21 Pt reports muscle pain 08/01/21 Pt reports he is feeling better 08/02/21 Pt is improving; reports fatigue and congestion are getting better
My daughter was experiencing severe pain during the time of her menstrual cycle. I took her to the doctor where it was discovered that she had a 10-millimeter fallopian cyst and fallopian tube obtrusion. She had surgery to remove the cyst and untwist the fallopian tube. She is doing much better now.
Headache, NauseaVomiting, arm pain, chills, stuffy nose Narrative:
Lump or swollen left breast; Lump or swollen left breast; Nipple is sore to the touch or pushing in on it is sore.; Feel some aching in left hand like arthritis; Feel some stiffness; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via unspecified route of administration in left arm on 25Feb2021 at 19:00 (at the age of 50 years) as a single dose for COVID-19 immunisation. Medical history included human immunodeficiency virus (HIV) and back pain. Concomitant medications within two weeks of vaccination included BIKTARVY, meloxicam (MANUFACTURER UNKNOWN), SEROQUEL, gabapentin (MANUFACTURER UNKNOWN) and vit D (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not have allergies to medications, food, or other products. On 03Mar2021 at 00:00, the patient experienced lump or swollen left breast, the nipple was sore to the touch or pushing in on it was sore, felt some aching in left hand like arthritis, stiffness and typical left arm soreness. Visual swelling compared to right breast was noticeable and swelling was right under the nipple size of quarter. It was unknown if any therapeutic measures were taken for the reported events. The clinical outcome for the events breast lump, breast swelling, sore nipple, hand pain and stiffness was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Patient received Moderna COVID vaccine on 2/2/21 and 3/2/21. On 10/16/21, patient was admitted to our facility for acute respiratory failure with hypoxia and COVID-19 pneumonia. As of today (10/19/21), patient is still admitted in our med/surg unit.
I developed aching all over within the next 1.5 hrs. (for 24 hrs.), in addition to the left upper arm mild swelling, redness, and tenderness (for 3 days).  Also, I experienced severe chills (for 24 hrs.).  Hot baths, warm clothing, rest, and motrin helped to relieve the severity of the symptoms.
All  listed symptoms (below) have not abated after three weeks Facial Flushing Anxiety Episodes Cardiac: atypical episodic heart palpations - heart pounding upon ambulation Tinnitus continuous  Flared up Rosacea Type 2 Caused gastritis flare ups - exasperated loss of normal digestion  Extreme neurological pain in lumbar region Disrupted sleep - hallucinating nightmares Skin crawling sensations Loss of feeling in soles of feet - bilateral  Episodic nerve tangling
On December 24, 2022, I had a fever, chills, body aches, nasal congestion, runny nose and dry cough. Also, I have had slight shortness of breath. My throat did not hurt but I did lose my voice. I went to the emergency room on January 4, 2023, and January 12, 2023, for my cough because it was so severe and due to my anxiety. My symptoms lasted about one week. My fever and chills lasted about 3 days. The only symptoms I have left today is my cough and shortness of breath.
This spontaneous report was received from a nurse concerning a patient of unknown age and gender (reported as a child). Medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with ROTATEQ (dose, strength and route were not reported) lot # H012983 expiration date 28-FEB-2014. Co-suspect and concomitant therapies were not reported. On an unknown date, the patient was administered expired ROTATEQ vaccine. No adverse effects reported. Additional information has been requested.